您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (2): 43-47.doi: 10.6040/j.issn.1671-7554.0.2021.1232

• 临床医学 • 上一篇    下一篇

2 809名体检人群中高血压与幽门螺杆菌感染的关联性

吕岩红,张志勉   

  1. 山东大学齐鲁医院健康管理中心, 山东 济南 250012
  • 发布日期:2022-01-25
  • 通讯作者: 张志勉. E-mail:zhangzhimian@126.com
  • 基金资助:
    山东省重大科技创新工程项目(2019JZZY011110)

Correlation of helicobacter pylori infection and hypertension in the 2,809 physical examination participants

LYU Yanhong, ZHANG Zhimian   

  1. Department of Health Management Center, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2022-01-25

摘要: 目的 探讨体检人群中高血压与幽门螺杆菌(Hp)感染的关联性,为高血压防治提供理论依据。 方法 选取2021年1月~6月进行体检的人员2 809例,进行13C-尿素呼气试验、血压及空腹血液等检查。根据检查结果将体检人员分为高血压组(n=485例)和非高血压组(n=2 324例)。比较两组Hp感染率,采用多元线性回归分析Hp感染与收缩压、舒张压、平均动脉压、脉压的关联性,采用多因素Logistic回归分析高血压的危险因素。 结果 高血压组Hp感染率显著高于非高血压组(P<0.001);多元线性回归分析结果显示,Hp感染与舒张压(β=0.862,95%CI:0.019~1.706,P=0.045)、平均动脉压(β=0.975,95%CI:0.074~1.876,P=0.034)呈正相关;多因素Logistic回归分析显示,Hp感染是高血压的独立危险因素(OR=1.667,95%CI:1.324~2.099, P<0.001)。 结论 Hp感染与舒张压、平均动脉压水平密切相关,可明显增加高血压的患病风险,提示积极控制Hp感染有利于预防或减少高血压的发生。

关键词: 幽门螺杆菌, 感染, 高血压, 健康体检, 危险因素

Abstract: Objective To explore the association between helicobacter pylori (Hp)infection and hypertension in the physical examination population, in order to provide a theoretical basis for the prevention and treatment of hypertension. Methods This cross-sectional study involved 2,809 participants who underwent 13C-urea breath test, blood pressure and fasting blood examination during January 2021 and June 2021. The participants were divided into hypertensive group(n=485)and non-hypertensive group(n=2 324)according to the examination results. The incidence of Hp infection was compared between two groups. The correlation of Hp infection with systolic pressure, diastolic pressure, mean arterial pressure, and pulse pressure was analyzed with multiple linear regression. The risk factors for hypertension were analyzed with multivariate Logistic regression. Results The incidence of Hp infection was significantly higher in the hypertensive group than in the non-hypertensive group(P<0.001). Multiple linear regression showed that Hp infection was positively associated with diastolic pressure(β=0.862, 95%CI: 0.019-1.706, P=0.045)and mean arterial pressure(β=0.975, 95%CI: 0.074-1.876, P=0.034). Multivariate Logistic regression showed that Hp infection was an independent risk factor for hypertension(OR=1.667, 95%CI: 1.324-2.099, P<0.001). Conclusion Hp infection is closely associated with diastolic blood pressure and mean arterial pressure, which can significantly increase the risk of hypertension, suggesting that active control of Hp infection is beneficial to preventing or reducing the incidence of hypertension.

Key words: Helicobacter pylori, Infection, Hypertension, Physical examination, Risk factor

中图分类号: 

  • R181.3
[1] Malfertheiner P, Megraud F, OMorain CA, et al. Management of helicobacter pylori infection-the maastricht v/florence consensus report [J]. Gut, 2017, 66(1): 6-30.
[2] 张万岱, 胡伏莲, 萧树东, 等. 中国自然人群幽门螺杆菌感染的流行病学调查[J]. 现代消化及介入诊疗, 2010, 15(5): 265-270. ZHANG Wandai, HU Fulian, XIAO Shudong, et al. Prevalence of helicobacter pylori infection in China [J]. Modern Digestion & Intervention, 2010, 15(5): 265-270.
[3] Pellicano R, Ianiro G, Fagoonee S, et al. Review: extragastric diseases and helicobacter pylori[J]. Helicobacter, 2020, 25(Suppl 1): e12741. doi: 10.1111/hel.12636.
[4] Gravina AG, Zagari RM, De Musis C, et al. Helicobacter pylori and extragastric diseases: a review [J]. World J Gastroenterol, 2018, 24(29): 3204-3221.[5] Wei L, Ding HG. Relationship between helicobacter pylori infection and nonalcoholic fatty liver disease: what should we expect from a meta-analysis [J]. Medicine, 2021, 100(31): e26706. doi: 10.1097/MD.000000000 0026706.
[6] Doheim MF, Altaweel AA, Elgendy MG, et al. Association between helicobacter pylori infection and stroke: a meta-analysis of 273,135 patients [J]. J Neurol, 2021, 268(9): 3238-3248.
[7] 于珍珍, 陈慧, 杨晓云, 等. 高尿酸血症、幽门螺杆菌感染与代谢综合征的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 76-80. YU Zhenzhen, CHEN Hui, YANG Xiaoyun, et al. Correlation between hyperuricemia, helicobacter pylori infection and metabolic syndrome [J]. Journal of Shandong University(Health Sciences), 2017, 55(5): 76-80.
[8] Yu XJ, Yang X, Feng L, et al. Association between helicobacter pylori infection and angiographically demonstrated coronary artery disease: a meta-analysis [J]. Exp Ther Med, 2017, 13(2): 787-793.
[9] Wan Z, Song L, Hu L, et al. Helicobacter pylori infection is associated with diabetes among Chinese adults [J]. J Diabetes Investig, 2020, 11(1): 199-205.
[10] Bravo D, Hoare A, Soto C, et al. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects [J]. World J of Gastroenterol, 2018, 24(28): 3071-3089.
[11] Vijayvergiya R, Vadivelu R. Role of helicobacter pylori infection in pathogenesis of atherosclerosis [J]. World J Cardiol, 2015, 7(3): 134-143.
[12] Zhang L, Chen Z, Xia X, et al. Helicobacter pylori infection selectively increases the risk for carotid atherosclerosis in young males [J]. Atherosclerosis, 2019, 291: 71-77. doi: 10.1016/j.atherosclerosis.2019.10. 005.
[13] Wan Z, Hu L, Hu M, et al. Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults [J]. J Hum Hypertens, 2018, 32(2): 158-164.
[14] Xiong X, Chen J, He M, et al. Helicobacter pylori infection and the prevalence of hypertension in Chinese adults: the dongfeng-tongji cohort [J]. J Hypertens(Greenwich), 2020, 22(8): 1389-1395.
[15] Upala S, Jaruvongvanich V, Riangwiwat T, et al. Association between helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis [J]. J Dig Dis, 2016, 17(7): 433-440.
[16] Nasrat SA, Nasrat AM. An alternative approach for the rising challenge of hypertensive illness via helicobacter pylori eradication [J]. Cardiol Res, 2015, 6(1): 221-225.
[17] Kopacova M, Koupil I, Seifert B, et al. Blood pressure and stature in helicobacter pylori positive and negative persons [J]. World J Gastroenterol, 2014, 20(19): 5625-5631.
[18] Abdollahi H, Shams S, Zahedi MJ, et al. IL-10, TNF-α and IFN-γ levels in serum and stomach mucosa of helicobacter pylori-infected patients [J]. Iran J Allergy Asthma Immunol, 2011, 10(4): 267-271.
[19] Xu S, Wu X, Zhang X, et al. CagA orchestrates eEF1A1 and PKCδ to induce interleukin-6 expression in helicobacter pylori-infected gastric epithelial cells [J]. Gut Pathog, 2020, 12: 31. doi: 10.1186/s13099-020-00 368-3.
[20] Chen Y, Wang X, Yu Y, et al. Serum exosomes of chronic gastritis patients infected with helicobacter pylori mediate IL-1α expression via IL-6 trans-signalling in gastric epithelial cells [J]. Clin Exp Immunol, 2018, 194(3): 339-349.
[21] Nakagawa H, Tamura T, Mitsuda Y, et al. Significant association between serum interleukin-6 and helicobacter pylori antibody levels among H. pylori-positive Japanese adults [J]. Mediators inflamm, 2013, 2013: 142358. doi: 10.1155/2013/142358.
[22] Franceschi F, Annalisa T, Teresa DR, et al. Role of helicobacter pylori infection on nutrition and metabolism [J]. World J Gastroenterol, 2014, 20(36): 12809-12817.
[23] Chen Y, Xu C, Xu H, et al. Persistent helicobacter pylori infection for more than 3 years leads to elevated serum homocysteine concentration: a retrospective cohort study based on a healthy Chinese population [J]. J Gastroenterol Hepatol, 2021, 36(11): 3077-3083.
[24] Shimamoto T, Yamamichi N, Gondo K, et al. The association of helicobacter pylori infection with serum lipid profiles: an evaluation based on a combination of meta-analysis and a propensity score-based observational approach [J]. PLoS One, 2020, 15(6): e0234433. doi: 10.1371/journal.pone.0234433.
[25] Watanabe J, Hamasaki M, Kotani K. The effect of helicobacter pylori eradication on lipid levels: a meta-analysis [J]. J Clin Med, 2021, 10(5): 904. doi: 10.3390/jcm10050904.
[26] Huang B, Chen Y, Xie Q, et al. CagA-positive helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum oxLDL and hsCRP in patients with coronary heart disease [J]. Dig Dis Sci, 2011, 56(1): 109-114.
[1] 吴逸南 葛志明 李方 贺红 姜虹 张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-.
[2] 孙红林,管玉强,于培儒,李磊,杜庆霞,丁浩. 支架植入治疗儿童主动脉缩窄并高血压的可行性及近中期疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 58-62.
[3] 黄玉真,吕琛,颜磊,李帅帅,张景雪,刘超,王银霞,桑岩岩,房鹛. 基于危险因素筛查的延续性院外管理对卵巢过度刺激综合征的预防效果[J]. 山东大学学报 (医学版), 2026, 64(4): 92-99.
[4] 齐硕,刘可宇,徐展望,谭国庆,张强. 改良活检优化宏基因组二代测序腰椎间盘感染早期诊断策略[J]. 山东大学学报 (医学版), 2026, 64(2): 96-103.
[5] 王皓正,张文雄. Q热伴胸腹主动脉瘤支架植入术后感染1例并文献复习[J]. 山东大学学报 (医学版), 2026, 64(1): 126-130.
[6] 逄锦宏,苏萍,乔俊鹏,陈巧巧,陈学禹,赵颖颖,施婕,孙晓茹,李秋春,何蕊言,范轶欧,迟蔚蔚. 老年人群可改变心血管危险因素聚集模式与脑卒中的关联[J]. 山东大学学报 (医学版), 2025, 63(9): 11-19.
[7] 张政,王建伟,杨玉娟,张宇,宋西成. 哮喘儿童2008及2019年免疫球蛋白E变化及相关危险因素[J]. 山东大学学报 (医学版), 2025, 63(7): 32-36.
[8] 王宁,郝秀梅,牛翔,黄金明,徐静雅. 中国中老年高血糖、血脂异常、高血压人群健康体检服务利用现状及影响因素[J]. 山东大学学报 (医学版), 2025, 63(7): 82-91.
[9] 葛雪,赵红艳. 疱疹病毒感染对重症肺炎患者临床预后及呼吸道微生态的影响[J]. 山东大学学报 (医学版), 2025, 63(6): 27-37.
[10] 李敬,郝盼盼. 急性心力衰竭患者出入院心率变化与预后相关性[J]. 山东大学学报 (医学版), 2025, 63(4): 75-82.
[11] 张骁驰, 吕婷婷, 于文浩, 李国傲, 高杉杉, 赵琦, 王立友. 2014—2019年我国极端降水与其他感染性腹泻的关联性研究[J]. 山东大学学报 (医学版), 2025, 63(4): 100-105.
[12] 李欣怡,张骁驰,李文,高杉杉,赵琦,张玮. 2018—2022年5~10月山东省热浪与学龄人群其他感染性腹泻发病的关联研究[J]. 山东大学学报 (医学版), 2025, 63(3): 110-116.
[13] 杨建平,管圣,戈小虎. 利福平浸泡移植物治疗布鲁氏菌感染的主/髂动脉瘤的临床经验[J]. 山东大学学报 (医学版), 2025, 63(12): 17-25.
[14] 程震宇,来庆国,吴梦涛. 髂股静脉支架置入术后再狭窄的影响因素研究进展[J]. 山东大学学报 (医学版), 2025, 63(12): 112-117.
[15] 程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!